Trial Profile
Study of COTI-2 in patients with Li-Fraumeni syndrome
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2016
Price :
$35
*
At a glance
- Drugs COTI 2 (Primary)
- Indications Li-Fraumeni syndrome
- Focus Adverse reactions
- Sponsors Cotinga Pharmaceuticals
- 19 Feb 2016 New trial record